Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check5 days agoChange DetectedThe page shows a minor revision update: v3.3.4 replaces v3.3.3, with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing sites in Chiba, Hokkaido, Hyōgo, Kanagawa, Osaka, and Tokyo, and removed the separate per-location subheadings (Chiba Locations, Hokkaido Locations, Hyōgo Locations, Kanagawa Locations, Osaka Locations, Tokyo Locations). Revision updated to v3.3.3.SummaryDifference0.7%

- Check54 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 in the page header. No substantive content changes to study details or eligibility criteria are evident from the visible page content.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding/status notice; this informational banner did not impact study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the study title, NCT number, locations, and inclusion/exclusion criteria appear unchanged.SummaryDifference0.4%

- Check105 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.